Home » Newsletters » BioWorld Science

BioWorld Science

July 2, 2008

View Archived Issues

OBI-1 effective for bleeds in hemophilia A patients

FDA approves Concerta for ADHD in adults

Indevus receives FDA approvable letter for Nebido

Salix initiates phase III rifaximin trials in non-constipation IBS

Study data reported for panobinostat in hematological cancers

Snapshots: Vorinostat in hematological malignancies

Lowering of Alzheimer's dementia risk similar with different NSAID types

Anika Therapeutics announces commercial availability of Monovisc in Europe

New treatments for gastrointestinal disorders disclosed in recent patent literature

FDA approves Aciphex 20 mg for short-term treatment of GERD

FDA grants orphan drug designation for bupivacaine in postherpetic neuralgia

Health Canada grants marketing authorization to Basilea's Zeftera for cSSSI

ALT-1102 signifcantly reduces disease activity in RRMS in phase IIa study

Myriad Genetics to discontinue development of Flurizan following disappointing phase III results

Wyeth KK and Takeda launch new formulation of Enbrel for RA in Japan

Tripep reports preliminary results from phase I/II clinical study of ChronVac-C in HCV

Recent patents disclose novel agents for psychiatric conditions

SGX Pharmaceuticals submits IND application to the FDA for SGX-393 in CML

New anticancer agents imparted in recent patent literature

Introgen submits BLA to FDA and MAA to EMEA for Advexin in head and neck cancer

Novartis Pharma initiates phase I study of oral PTH-134 in postmenopausal osteoporosis

deCode reports positive results from pharmacology study of antiplatelet therapy DG-041

Novel DPP-IV inhibitor profiled at LG Life Sciences

Inhaled liposomal ciprofloxacin reduces bacterial infection, improves lung function in CF study

NanoViricides to initiate animal efficacy studies of EKC-Cide in Japan

Synthetic Blood International changes name to Oxygen Biotherapeutics

VioQuest submits 510(k) application to FDA for Xyfid for skin disorders

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Dec. 18, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Dec. 18, 2025.
Apollo’s APL-4098 shows potent antileukemic effects
BioWorld Science
Apollo Therapeutics Ltd. has developed APL-4098, a small-molecule general control nonderepressible 2 (GCN2) inhibitor for the potential treatment of AML.
ABS-1230 controls seizures in KCNT1-driven severe epilepsy
BioWorld Science
Mutations in the KCNT1 gene produce gain-of-function effects that lead to overactivation of the potassium channel and consequent disruption of normal neuronal...
DEE-lightful: Praxis’ phase II results allow stock to flex its muscle
BioWorld
Positive efficacy results led to Praxis Precision Medicines Inc.’s phase II Embold study in developmental and epileptic encephalopathies (DEEs) being halted...